Reimagining Biopharma: Precision Medicine, Patients, and Purpose with Takeda CEO-Elect

About this episode

Julie Kim, CEO-elect of Takeda Pharmaceuticals, discusses precision medicine and the future of biopharma with Yassaman Salas.

Takeda Pharmaceuticals operates at the intersection of deep scientific innovation and complex global healthcare systems, with a portfolio spanning gastroenterology, oncology, neuroscience, rare diseases, and plasma-derived therapies. CEO-elect Julie Kim joins Yassaman Salas, global co-head of the Healthcare Group within Investment Banking at Goldman Sachs, to discuss the promise of precision medicine, the role of AI and real-world data in accelerating development and access, and how she plans to sharpen Takeda’s growth story while preserving its patient-first, values-driven culture. This episode was recorded on October 31, 2025. The opinions and views expressed herein are as of the date of publication, subject to change without notice, and may not necessarily reflect the institutional views of Goldman Sachs or its affiliates. The material provided is intended for informational purposes only, and does not constitute investment advice, a recommendation from any Goldman Sachs entity to take any particular action, or an offer or solicitation to purchase or sell any securities or financial products. This material may contain forward-looking statements. Past performance is not…

People in this episode

Host: Yassaman Salas

Guest: Julie Kim

Topics covered

• biopharma
• precision medicine
• healthcare systems
• AI in healthcare
• patient-first culture
• growth strategy

Keywords

• biopharma
• precision medicine
• Takeda
• AI
• healthcare
• patient-first
• growth strategy

Mentioned in this episode

Organizations: Takeda Pharmaceuticals, Goldman Sachs

More episodes of Talks at GS

• Leading Through Complexity: EY’s Janet Truncale on Leadership, AI, and the Modern Boardroom · June 8, 2026 · 21 min
• Caitlin Clark on Navigating Pressure and the Future of the WNBA · May 21, 2026 · 17 min
• McLaren Racing's Lando Norris and Zak Brown: Building a High-Performance Team · May 13, 2026 · 23 min
• Winning the Right to Invest: 20VC’s Harry Stebbings · April 27, 2026 · 19 min
• Holocaust Survivors on Hope, Survival, and the Responsibility to Remember · April 13, 2026 · 35 min
• Sir Sadiq Khan on London’s Global Edge—and What Comes Next · April 8, 2026 · 24 min